HKUMed Research Validates TCM Liver-Breast Cancer Theory: Fatty Liver Linked to Deteriorating Breast Cancer
July 11, 2024
July 11, 2024
HONG KONG, July 11 (TNSres) -- The University of Hong Kong issued the following news release:
A research team from the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has made a remarkable discovery that patients with non-alcoholic fatty liver disease (commonly known as fatty liver disease) exhibit excessive production of a hepatokine called 'Fibroblast Growth Factor 21 (FGF21)' in their liver, which may accelerate the growth of breast cance . . .
A research team from the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has made a remarkable discovery that patients with non-alcoholic fatty liver disease (commonly known as fatty liver disease) exhibit excessive production of a hepatokine called 'Fibroblast Growth Factor 21 (FGF21)' in their liver, which may accelerate the growth of breast cance . . .